跳至主要内容
临床试验/DRKS00024950
DRKS00024950尚未招募不适用

To investigate calcium metabolism as a therapeutic target in multiple sclerosis (MS)

niversitätsmedizin Göttingen0 个研究点目标入组 90 人开始时间: 2021年4月1日最近更新:
适应症

试验速览

阶段
不适用
状态
尚未招募
发起方
入组人数
90

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

年龄范围
18 Years 至 80 Years(—)
性别
All

入选标准

  • In the group of patients without CCB therapy, no CCB therapy for at least 3 months
  • In the cohort of patients with CCB therapy, no CCB therapy for at least 3 months
  • Patients who have given written informed consent based on GCP guidelines

排除标准

  • Pregnancy
  • Known autoimmune disease
  • Acute/chronic infection
  • Active Malignancy
  • Chronic kidney disease > CKD stage 4
  • Hypo-/Hypercalcemia
  • Intake of calcium, vitamin D and its derivates
  • Calcineurin-inhibitor treatment
  • Therapy with calcimimetica
  • Hyperparathyreoidism
  • Patients who have not given written informed consent based on GCP guidelines

研究者

发起方
niversitätsmedizin Göttingen

相似试验